At close: December 20 at 4:00:01 PM EST
After hours: December 20 at 4:09:47 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
--
--
22,378.0000
Operating Expense
60,541.0000
67,637.0000
75,909.0000
70,765.0000
63,603.0000
Operating Income
-60,541.0000
-67,637.0000
-75,909.0000
-70,765.0000
-41,225.0000
Other Income Expense
2,023.0000
4,914.0000
1,176.0000
1,376.0000
4,622.0000
Pretax Income
-58,518.0000
-62,723.0000
-74,733.0000
-69,389.0000
-36,603.0000
Net Income Common Stockholders
-58,518.0000
-62,723.0000
-74,733.0000
-69,389.0000
-36,603.0000
Diluted NI Available to Com Stockholders
-58,518.0000
-62,723.0000
-74,733.0000
-69,389.0000
-36,603.0000
Basic EPS
-2.10
-2.25
-2.69
-2.51
-1.33
Diluted EPS
-2.10
-2.25
-2.69
-2.51
-1.33
Basic Average Shares
27,938.5680
27,836.5840
27,744.2090
27,615.9770
27,532.1770
Diluted Average Shares
27,938.5680
27,836.5840
27,744.2090
27,615.9770
27,532.1770
Total Operating Income as Reported
-63,083.0000
-67,637.0000
-75,909.0000
-70,765.0000
-41,225.0000
Total Expenses
60,541.0000
67,637.0000
75,909.0000
70,765.0000
63,603.0000
Net Income from Continuing & Discontinued Operation
-58,518.0000
-62,723.0000
-74,733.0000
-69,389.0000
-36,603.0000
Normalized Income
-55,976.0000
-62,723.0000
-74,733.0000
-69,389.0000
-36,603.0000
EBIT
-60,541.0000
-67,637.0000
-75,909.0000
-70,765.0000
-41,225.0000
EBITDA
-57,526.0000
-63,953.0000
-71,785.0000
-66,588.0000
-37,812.0000
Reconciled Depreciation
3,015.0000
3,684.0000
4,124.0000
4,177.0000
3,413.0000
Net Income from Continuing Operation Net Minority Interest
-58,518.0000
-62,723.0000
-74,733.0000
-69,389.0000
-36,603.0000
Total Unusual Items Excluding Goodwill
-2,542.0000
--
--
--
--
Total Unusual Items
-2,542.0000
--
--
--
--
Normalized EBITDA
-54,984.0000
-63,953.0000
-71,785.0000
-66,588.0000
-37,812.0000
12/31/2020 - 5/9/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ASMB Assembly Biosciences, Inc.
15.21
-3.80%
HLVX HilleVax, Inc.
1.8600
+1.64%
IKNA Ikena Oncology, Inc.
1.5500
-3.73%
EPIX ESSA Pharma Inc.
1.6000
0.00%
ANTX AN2 Therapeutics, Inc.
1.2600
-0.79%
SPRO Spero Therapeutics, Inc.
0.9551
-4.30%
GLTO Galecto, Inc.
4.7000
+0.43%
CTMX CytomX Therapeutics, Inc.
1.0900
-0.91%
GLPG.AS Galapagos NV
25.58
+0.16%
OKUR OnKure Therapeutics, Inc.
8.38
+4.10%